Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/24 18:25 | 10/17/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Fust Matthew K | MA | D | S.dm | -371 | 17.03 | 0 | -22 | -52 | 20 | D | |||||||||||||||
10/11/24 16:10 | 10/9/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Lenz Robert A. | MA | O | Head of | S.m | -208 | 15.06 | 0 | -14 | -4 | 315 | D | ||||||||||||||
9/19/24 16:35 | 9/17/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Lenz Robert A. | MA | O | Head of | S.m | -493 | 11.89 | 0 | -41 | -11 | 329 | D | ||||||||||||||
9/16/24 16:05 | 9/12/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Lenz Robert A. | MA | O | Head of | S | -377 | 11.43 | 0 | -33 | -8 | 370 | D | ||||||||||||||
8/27/24 17:58 | 8/27/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Pinto Joshua | MA | O | CFO | S | -179 | 11.39 | 0 | -16 | -7 | 224 | I | ||||||||||||||
8/26/24 18:17 | 8/22/24 | NMRA | Health | BioPrd | Biological Products, (No Diag | Pinto Joshua | MA | O | CFO | S.m | -984 | 11.67 | 0 | -84 | -26 | 240 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |